Zimmer Biomet Announces Executive Reorganization and Americas Leadership Promotions

Executive Summary

On September 8, 2026, Zimmer Biomet Holdings, Inc. (NYSE: ZBH) filed a Form 8-K disclosing a restructuring of its executive leadership under Item 5.02 and Item 7.01.

Key Disclosures

1. Executive Departure:

   • Kevin Thornal, Group President, Global Businesses and the Americas, was notified that his role has been eliminated due to restructuring. He will depart the company effective September 30, 2026.
   • Severance Terms: Eligible for standard severance under the Restated Executive Severance Plan, consisting of a lump-sum payment equal to 12 months of annual base salary plus target annual bonus, and 12 months of COBRA premium equivalents, subject to a release of claims.

2. Commercial Leadership Promotions (Effective October 1, 2026):

   • Gary Campbell: Promoted to President, Americas, overseeing commercial operations across the U.S., Canada, and Latin America.
   • Brian Hatcher: Promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery, taking global portfolio oversight including Global Knees and Hips.
   • Bradley Kessler: Promoted to President, Americas – Robotics, Technology and Data.

3. Financial Outlook:

   • Zimmer Biomet reiterated its full-year 2026 financial outlook previously issued on August 5, 2026.